The strong beat and guidance raise validate the turnaround narrative, likely driving positive momentum. However, Q4 organic revenue is guided to decline low-single digits YoY, so watch for commentary on demand sustainability and the pace of cost transformation. The $529M cash position and active buyback provide downside support.
Price Chart
Executive Summary
Azenta (AZTA) reported Q3 fiscal 2026 results with non-GAAP EPS of $0.16, crushing consensus of $0.10 (+60%), and revenue of $161M beating $149.2M (+7.9%). The company raised its full-year fiscal 2026 revenue guidance to $613-618M (from $603-621M) and organic revenue growth forecast to flat-to-up 1% (from down 2% to up 1%), signaling improvement in its Sample Management Solutions and Multiomics segments despite a continued GAAP operating loss.
Key Financial Metrics
Key Facts
- Revenue from continuing operations was $161M, up 12% YoY (organic growth of 9%).
- Non-GAAP diluted EPS was $0.16, compared to consensus of $0.10.
- GAAP diluted EPS from continuing operations was -$0.03.
- Sample Management Solutions revenue grew 14% YoY to $88M; Multiomics revenue grew 10% to $73M.
- Adjusted EBITDA was $18.5M with an 11.4% margin.
- Full-year fiscal 2026 revenue guidance raised to $613-618M from $603-621M; organic revenue growth guidance improved to flat-to-up 1%.
- Ended quarter with $529M in cash, cash equivalents, and marketable securities.
- Repurchased 2.3M shares for $50M year-to-date under the $250M buyback program.
- Operating cash flow was $1M; free cash flow was -$5M for the quarter.
- GAAP operating loss was -$4.2M; non-GAAP operating income was $4.7M.
Financial Impact
Non-GAAP EPS beat by $0.06 (60% upside vs consensus); revenue beat by ~$11.8M (7.9%). Full-year guidance raised, implying ~$9M midpoint increase from prior range.
Risk Factors
- GAAP operating loss continues (-$2.6M margin), indicating underlying profitability pressure.
- Free cash flow is negative (-$5M), with operating cash flow of only $1M.
- Q4 fiscal 2026 organic revenue expected to decline low-single digits YoY, signaling uneven demand.
- Transformation and restructuring costs remain elevated, clouding GAAP earnings visibility.
- $149M goodwill impairment in Q2 weighs on balance sheet and confidence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302842967 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $31.33 $32.04 | ▲ +2.27% | ▲ +3.48% | $38.75 (+23.68%) |
Aug 24, 2026 5w ago | 8-K | $32.88 $32.65 | ▼ −0.70% | ▼ −1.17% | $38.75 (+17.85%) |
Aug 8, 2026 7w ago | Institutional Cluster | $33.33 $33.58 | ▲ +0.75% | ▲ +0.80% | $38.75 (+16.26%) |
Aug 4, 2026 8w ago | Press Release | $31.82 $33.53 | ▲ +5.37% | ▲ +5.02% | $38.75 (+21.78%) |
Jul 8, 2026 12w ago | 8-K | $24.51 $25.44 | ▲ +3.79% | ▲ +2.93% | $38.75 (+58.10%) |
May 5, 2026 21w ago | 8-K | $18.38 $17.53 | ▲ +4.62% | ▲ +5.76% | $38.75 (−110.83%) |
Apr 7, 2026 25w ago | 8-K | $21.71 $24.26 | ▲ +11.75% | ▲ +6.42% | $38.75 (+78.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access